224 related articles for article (PubMed ID: 27518527)
1. Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report.
Ravindra VM; Raheja A; Corn H; Driscoll M; Welt C; Simmons DL; Couldwell WT
J Neurosurg; 2017 May; 126(5):1725-1730. PubMed ID: 27518527
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
[TBL] [Abstract][Full Text] [Related]
3. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly and pheochromocytoma: report of a rare coexistence.
Sleilati GG; Kovacs KT; Honasoge M
Endocr Pract; 2002; 8(1):54-60. PubMed ID: 11939762
[TBL] [Abstract][Full Text] [Related]
5. Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in pituitary hyperplasia.
Vidal S; Horvath E; Kovacs K; Lloyd RV; Smyth HS
Mod Pathol; 2001 Jan; 14(1):20-8. PubMed ID: 11211306
[TBL] [Abstract][Full Text] [Related]
6. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
7. Recurrent, transformed non-Hodgkin's lymphoma presenting as chiasmal syndrome with hyperprolactinemia and hypopituitarism.
Sumrall A; Herrin V
J Miss State Med Assoc; 2010 Feb; 51(2):35-6. PubMed ID: 20827870
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
9. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
Ezzat S; Asa SL; Stefaneanu L; Whittom R; Smyth HS; Horvath E; Kovacs K; Frohman LA
J Clin Endocrinol Metab; 1994 Mar; 78(3):555-60. PubMed ID: 8126126
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
11. Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma.
Vieira Neto L; Taboada GF; Corrêa LL; Polo J; Nascimento AF; Chimelli L; Rumilla K; Gadelha MR
Endocr Pathol; 2007; 18(1):46-52. PubMed ID: 17652801
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: case report.
Altstadt TJ; Azzarelli B; Bevering C; Edmondson J; Nelson PB
Neurosurgery; 2002 Jun; 50(6):1356-9; discussion 1360. PubMed ID: 12015856
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
[No Abstract] [Full Text] [Related]
14. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
16. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
[TBL] [Abstract][Full Text] [Related]
17. Invasive Crooke cell adenoma in a patient with diffuse large B-cell lymphoma.
Schwann K; Bogiatzi C; Algird A; Lu JQ
J Clin Neurosci; 2020 Mar; 73():318-321. PubMed ID: 31937501
[TBL] [Abstract][Full Text] [Related]
18. Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series.
Kawaguchi T; Ogawa Y; Tominaga T
J Med Case Rep; 2019 Mar; 13(1):85. PubMed ID: 30862315
[TBL] [Abstract][Full Text] [Related]
19. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
20. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
Roberts E; Oncale M; Safah H; Schmieg J
J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
